{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T03:20:43Z","timestamp":1785122443538,"version":"3.55.0"},"reference-count":21,"publisher":"Azerbaijan Medical Journal","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>\u0412 \u0441\u0442\u0430\u0442\u044c\u0435 \u043f\u0440\u0435\u0434\u0441\u0442\u0430\u0432\u043b\u0435\u043d\u0430 \u0438\u043d\u0444\u043e\u0440\u043c\u0430\u0446\u0438\u044f \u043e\u0431 \u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u043d\u0438\u0438, \u043f\u0440\u043e\u0432\u0435\u0434\u0451\u043d\u043d\u043e\u043c \u0441 \u0446\u0435\u043b\u044c\u044e \u0438\u0437\u0443\u0447\u0435\u043d\u0438\u044f \u0440\u0430\u0441\u043f\u0440\u043e\u0441\u0442\u0440\u0430\u00ad\u043d\u0435\u043d\u043d\u043e\u0441\u0442\u0438 \u0440\u0430\u0441\u0441\u0435\u044f\u043d\u043d\u043e\u0433\u043e \u0441\u043a\u043b\u0435\u0440\u043e\u0437\u0430 (\u0420\u0421) \u0438 \u0443\u0434\u0435\u043b\u044c\u043d\u043e\u0433\u043e \u0432\u0435\u0441\u0430 \u0435\u0433\u043e \u043a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0438\u0445 \u0444\u043e\u0440\u043c \u0432 \u041a\u0430\u0440\u0430\u0431\u0430\u0445\u0441\u043a\u043e\u043c \u0438 \u0412\u043e\u0441\u0442\u043e\u0447\u043d\u043e-\u0417\u0430\u043d\u0433\u0435\u0437\u0443\u0440\u0441\u043a\u043e\u043c \u044d\u043a\u043e\u043d\u043e\u043c\u0438\u0447\u0435\u0441\u043a\u0438\u0445 \u0440\u0430\u0439\u043e\u043d\u0430\u0445. \u0412 \u0442\u0435\u0447\u0435\u043d\u0438\u0435 10 \u043b\u0435\u0442 (01.01.2013-31.12.2022) \u0441\u043f\u0435\u00ad\u0446\u0438\u0430\u043b\u044c\u043d\u043e\u0439 \u044d\u043a\u0441\u043f\u0435\u0440\u0442\u043d\u043e\u0439 \u043a\u043e\u043c\u0438\u0441\u0441\u0438\u0435\u0439 \u043f\u0440\u0438 \u041d\u0435\u0432\u0440\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u043e\u043c \u0446\u0435\u043d\u0442\u0440\u0435 \u041c\u0438\u043d\u0438\u0441\u0442\u0435\u0440\u0441\u0442\u0432\u0430 \u0417\u0434\u0440\u0430\u0432\u043e\u043e\u0445\u0440\u0430\u043d\u0435\u043d\u0438\u044f \u0410\u0437\u0435\u0440\u0431\u0430\u0439\u0434\u0436\u0430\u043d\u0441\u043a\u043e\u0439 \u0420\u0435\u0441\u043f\u0443\u0431\u043b\u0438\u043a\u0438 \u0431\u044b\u043b\u043e \u043e\u0431\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u043d\u043e 224 \u043f\u0430\u0446\u0438\u0435\u043d\u0442\u0430 \u0441 \u0434\u0438\u0430\u0433\u043d\u043e\u0437\u043e\u043c \u0420\u0421 \u0438\u0437 \u0443\u043a\u0430\u0437\u0430\u043d\u043d\u044b\u0445 \u044d\u043a\u043e\u043d\u043e\u043c\u0438\u0447\u0435\u0441\u043a\u0438\u0445 \u0440\u0430\u0439\u043e\u043d\u043e\u0432, \u0430 \u0442\u0430\u043a\u0436\u0435 \u0438\u0437\u0443\u0447\u0435\u043d\u0430 \u0438\u0445 \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u0430\u044f \u0434\u043e\u043a\u0443\u043c\u0435\u043d\u0442\u0430\u0446\u0438\u044f. \u0421\u0440\u0435\u0434\u043d\u0438\u0439 \u0432\u043e\u0437\u0440\u0430\u0441\u0442 \u043f\u0430\u0446\u0438\u0435\u043d\u0442\u043e\u0432 \u043d\u0430 \u043c\u043e\u043c\u0435\u043d\u0442 \u043f\u043e\u0441\u0442\u0430\u043d\u043e\u0432\u043a\u0438 \u0434\u0438\u0430\u0433\u043d\u043e\u0437\u0430 \u0441\u043e\u0441\u0442\u0430\u0432\u0438\u043b 34,81\u00b17,78 \u0433\u043e\u0434\u0430. \u0421\u0440\u0435\u0434\u0438 \u043a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0438\u0445 \u0444\u043e\u0440\u043c \u0420\u0421 \u043d\u0430\u0438\u0431\u043e\u043b\u0435\u0435 \u0447\u0430\u0441\u0442\u043e \u0432\u0441\u0442\u0440\u0435\u0447\u0430\u043b\u0438\u0441\u044c \u0440\u0435\u0446\u0438\u0434\u0438\u0432\u0438\u0440\u0443\u044e\u0449\u0435-\u0440\u0435\u043c\u0438\u0442\u0442\u0438\u0440\u0443\u044e\u0449\u0438\u0439 \u0420\u0421 (80,4%) \u0438 \u0432\u0442\u043e\u0440\u0438\u0447\u043d\u043e-\u043f\u0440\u043e\u0433\u0440\u0435\u0441\u00ad\u0441\u0438\u0440\u0443\u044e\u0449\u0438\u0439 \u0420\u0421 (15,2%). \u041a \u043a\u043e\u043d\u0446\u0443 \u043f\u0435\u0440\u0438\u043e\u0434\u0430 \u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u043d\u0438\u044f \u0440\u0430\u0441\u043f\u0440\u043e\u0441\u0442\u0440\u0430\u043d\u0451\u043d\u043d\u043e\u0441\u0442\u044c \u0420\u0421 \u0432 \u0440\u0435\u0433\u0438\u043e\u043d\u0435 \u0441\u043e\u0441\u0442\u0430\u0432\u0438\u043b\u0430 20,83\u00b11,42 \u043d\u0430 100 000 \u043d\u0430\u0441\u0435\u043b\u0435\u043d\u0438\u044f (95% \u0414\u0418 \u2013 18,05-23,61). \u0420\u0430\u0441\u043f\u0440\u043e\u0441\u0442\u0440\u0430\u043d\u0451\u043d\u043d\u043e\u0441\u0442\u044c \u0420\u0421 \u0441\u0440\u0435\u0434\u0438 \u0436\u0435\u043d\u0449\u0438\u043d \u0431\u044b\u043b\u0430 \u0437\u043d\u0430\u0447\u0438\u0442\u0435\u043b\u044c\u043d\u043e \u0432\u044b\u0448\u0435, \u0447\u0435\u043c \u0441\u0440\u0435\u0434\u0438 \u043c\u0443\u0436\u0447\u0438\u043d (\u0440&lt;0,001).<\/jats:p>\n                                                                                            <jats:p>M\u0259qal\u0259d\u0259 Qaraba\u011f v\u0259 \u015e\u0259rgi Z\u0259ng\u0259zur iqtisadi rayonlar\u0131nda da\u011f\u0131n\u0131q sklerozun (DS) yay\u0131lmas\u0131n\u0131n v\u0259 klinik gedi\u015fin\u0259 g\u00f6r\u0259 tipl\u0259rinin x\u00fcsusi \u00e7\u0259kisini ara\u015fd\u0131rmaq m\u0259qs\u0259dil\u0259 apar\u0131lm\u0131\u015f t\u0259dqiqat i\u015fi haqq\u0131nda m\u0259lumat verilmi\u015fdir. 10 il (01.01.2013-31.12.2022) \u0259rzind\u0259 Az\u0259rbaycan Respublikas\u0131 S\u0259hiyy\u0259 Nazirliyinin Nevroloji M\u0259rk\u0259zind\u0259 x\u00fcsusi ekspert komissiyas\u0131 t\u0259r\u0259find\u0259n ad\u0131 \u00e7\u0259kil\u0259n iqtisadi rayonlardan DS diaqnozlu 224 x\u0259st\u0259 m\u00fcayin\u0259 edilmi\u015f v\u0259 tibbi s\u0259n\u0259dl\u0259ri ara\u015fd\u0131r\u0131lm\u0131\u015fd\u0131r. Diaqnoz qoyulark\u0259n x\u0259st\u0259l\u0259rin orta ya\u015f\u0131 34,81\u00b17,78 olmu\u015fdur. DS-nin klinik tipl\u0259ri aras\u0131nda daha \u00e7ox rast g\u0259lin\u0259n residivver\u0259n DS (80,4%) v\u0259 ikincili proqressivl\u0259\u015f\u0259n DS (15,2%) olmu\u015fdur. T\u0259dqiqat m\u00fcdd\u0259tinin sonuna regionda DS-in yay\u0131lmas\u0131 100000 n\u0259f\u0259r\u0259 20,83\u00b11,42 (95% CI \u2013 18,05-23,61) olmu\u015fdur. Qad\u0131nlar aras\u0131nda DS-nin yay\u0131lmas\u0131 ki\u015fil\u0259rl\u0259 m\u00fcqayis\u0259d\u0259 \u0259h\u0259miyy\u0259tli d\u0259r\u0259c\u0259d\u0259 y\u00fcks\u0259k olmu\u015fdur \u2013 p&lt;0,001.<\/jats:p>\n                                                    <jats:p>The article presents information about a study conducted to investigate the prevalence of multiple sclerosis (MS) and the proportion of its clinical forms in the Karabakh and East Zangezur economic regions. Over a period of 10 years (01.01.2013\u201331.12.2022), a special expert commission at the Neurology Center of the Ministry of Health of the Republic of Azerbaijan examined 224 patients diagnosed with MS from the specified economic regions and analyzed their medical records. The average age of patients at the time of diagnosis was 34.81\u00b17.78 years. Among the clinical forms of MS, the most common were relapsing-remitting MS (80.4%) and secondary progressive MS (15.2%). By the end of the study period, the prevalence of MS in the region was 20.83\u00b11.42 per 100,000 people (95% CI \u2013 18.05-23.61). The prevalence of MS among women was significantly higher than among men (P&lt;0.001).<\/jats:p>","DOI":"10.34921\/amj.2025.2.021","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T09:35:28Z","timestamp":1753954528000},"page":"130-136","source":"Crossref","is-referenced-by-count":1,"title":["\u0420\u0410\u0421\u041f\u0420\u041e\u0421\u0422\u0420\u0410\u041d\u0415\u041d\u041d\u041e\u0421\u0422\u042c \u0420\u0410\u0421\u0421\u0415\u042f\u041d\u041d\u041e\u0413\u041e \u0421\u041a\u041b\u0415\u0420\u041e\u0417\u0410 \u0412 \u041e\u0421\u0412\u041e\u0411\u041e\u0416\u0414\u0401\u041d\u041d\u042b\u0425 \u041e\u0422 \u041e\u041a\u041a\u0423\u041f\u0410\u0426\u0418\u0418 \u0422\u0415\u0420\u0420\u0418\u0422\u041e\u0420\u0418\u042f\u0425 \u0410\u0417\u0415\u0420\u0411\u0410\u0419\u0414\u0416\u0410\u041d\u0410"],"prefix":"10.34921","author":[{"given":"\u0420.\u0420.","family":"\u0410\u043b\u0438\u0435\u0432","sequence":"first","affiliation":[{"name":"\u0410\u0437\u0435\u0440\u0431\u0430\u0439\u0434\u0436\u0430\u043d\u0441\u043a\u0438\u0439 \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u0438\u0439 \u0443\u043d\u0438\u0432\u0435\u0440\u0441\u0438\u0442\u0435\u0442"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"50808","published-online":{"date-parts":[[2025,6,25]]},"reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Walton C., King R., Rechtman L., Kaye W. et al. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition \/\/ Mult Scler. 2020 Dec;26(14):1816-1821. doi: 10.1177\/1352458520970841","DOI":"10.1177\/1352458520970841"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Jakimovski D., Bittner S., Zivadinov R., Morrow S.A., Benedict R.H., Zipp F., Weinstock-Guttman B. Multiple sclerosis \/\/ Lancet. 2024 Jan 13;403(10422):183-202. doi: 10.1016\/S0140-6736(23)01473-3","DOI":"10.1016\/S0140-6736(23)01473-3"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Aliyev, R. Characteristics of multiple sclerosis in urban and rural areas of Azerbaijan. Azerbaijan Medical Journal, 2024, (1), 31\u201338. https:\/\/doi.org\/10.34921\/amj.2024.1.005","DOI":"10.34921\/amj.2024.1.005"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Aliyev R.R., Mehtiyeva Sh.N., Shiraliyeva R.K. Clinical and epidemiological characteristics of multiple sclerosis in the southern region of the Republic of Azerbaijan \/\/ Pak J Med Sci. 2025;41(2):437-442. doi: 10.12669\/ pjms. 41.2.11373","DOI":"10.12669\/pjms.41.2.11373"},{"key":"5","unstructured":"\u201cAz\u0259rbaycan\u0131n demoqrafik g\u00f6st\u0259ricil\u0259ri\u201d Statistik m\u0259cmu\u0259\/2023. R\u0259smi n\u0259\u015fr. Az\u0259rbaycan Respublikas\u0131 D\u00f6vl\u0259t Statistika Komit\u0259si. Bak\u0131, \u201c\u00c7a\u015f\u0131o\u011flu E\u0130-MMC\u201d 2023. 590 s."},{"key":"6","unstructured":"\u201cDa\u011f\u0131n\u0131q skleroz x\u0259st\u0259liyinin m\u00fcalic\u0259si, profilaktikas\u0131 v\u0259 onunla m\u00fcbariz\u0259 t\u0259dbirl\u0259rin\u0259 dair D\u00f6vl\u0259t Proqram\u0131\u201dn\u0131n t\u0259sdiq edilm\u0259si haqq\u0131nda Az\u0259rbaycan Respublikas\u0131 Prezidentinin S\u0259r\u0259ncam\u0131. Bak\u0131 \u015f\u0259h\u0259ri, 13 noyabr 2012-ci il, \u21162542. Az\u0259rbaycan Respublikas\u0131n\u0131n \u018fdliyy\u0259 Nazirliyi, h\u00fcquqi aktlar\u0131n vahid elektron bazas\u0131. https:\/\/e-qanun.az\/framework\/24678"},{"key":"7","unstructured":"\u015eir\u0259liyeva R.K., M\u0259mm\u0259db\u0259yov F., Sad\u0131xova Z.M., M\u0259mm\u0259db\u0259yli A.K. v\u0259 h\u0259mm. Da\u011f\u0131n\u0131q sklerozun diaqnostika v\u0259 m\u00fcalic\u0259si \u00fczr\u0259 klinik protokol. \u201cNEYOSTAR\u201d MMC, Bak\u0131-2013. 40 s\u0259h."},{"key":"8","unstructured":"Richard J. Rossi. Applied Biostatistics for the Health Sciences, 2nd Edition. Wiley. 2022. 688 pages. ISBN: 978-1-119-72270-0"},{"key":"9","doi-asserted-by":"crossref","unstructured":"\u0421\u043f\u0438\u0440\u0438\u043d \u041d.\u041d., \u041a\u0430\u0441\u0430\u0442\u043a\u0438\u043d \u0414.\u0421., \u0421\u0442\u0435\u043f\u0430\u043d\u043e\u0432 \u0418.\u041e., \u0428\u0438\u043f\u043e\u0432\u0430 \u0415.\u0413. \u0438 \u0434\u0440. \u0414\u0438\u043d\u0430\u043c\u0438\u043a\u0430 \u043e\u0441\u043d\u043e\u0432\u043d\u044b\u0445 \u044d\u043f\u0438\u0434\u0435\u043c\u0438\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0445 \u043f\u043e\u043a\u0430\u0437\u0430\u0442\u0435\u043b\u0435\u0439 \u0440\u0430\u0441\u0441\u0435\u044f\u043d\u043d\u043e\u0433\u043e \u0441\u043a\u043b\u0435\u0440\u043e\u0437\u0430 \u043f\u043e \u0440\u0435\u0437\u0443\u043b\u044c\u0442\u0430\u0442\u0430\u043c \u0441\u0440\u0430\u0432\u043d\u0435\u043d\u0438\u044f \u0440\u0435\u0433\u0438\u0441\u0442\u0440\u043e\u0432 \u043f\u0430\u0446\u0438\u0435\u043d\u0442\u043e\u0432 1999 \u0438 2019 \u0433\u0433. \u0432 \u042f\u0440\u043e\u0441\u043b\u0430\u0432\u043b\u0435 \/\/ \u0416\u0443\u0440\u043d\u0430\u043b \u043d\u0435\u0432\u0440\u043e\u043b\u043e\u0433\u0438\u0438 \u0438 \u043f\u0441\u0438\u0445\u0438\u0430\u0442\u0440\u0438\u0438 \u0438\u043c. \u0421.\u0421. \u041a\u043e\u0440\u0441\u0430\u043a\u043e\u0432\u0430. \u0421\u043f\u0435\u0446\u0432\u044b\u043f\u0443\u0441\u043a\u0438. 2020;12(7\u20112): 48\u201153 [Spirin N.N., Kasatkin D.S., Stepanov I.O., Shipova Ye.G., i dr. Dinamika osnovnykh epidemiologicheskikh pokazateley rasseyannogo skleroza po rezul&apos;tatam sravneniya registrov patsiyentov 1999 i 2019 gg. v Yaroslavle \/\/ Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. Spetsvypuski. 2020;12(7 2): 48 53]","DOI":"10.17116\/jnevro202012007248"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Moghtaderi A., Shahidi-Pourakbari M., Izadi S., Khosravi A., Hashemzehi Z. Ongoing increase in incidence and prevalence of multiple sclerosis in south-eastern Iran: A three decade study \/\/ Mult Scler Relat Disord. 2023 Mar;71:104557. doi: 10.1016\/j.msard.2023.104557","DOI":"10.1016\/j.msard.2023.104557"},{"key":"11","doi-asserted-by":"crossref","unstructured":"B\u00f6l\u00fck C., T\u00fcrk B\u00f6r\u00fc U., Ta\u015fdemir M., Gezer T. Epidemiology of Multiple Sclerosis in Turkey; A Ten-Year Trend in Rural Cities \/\/ Turk J Neurol 2021;27:41-45 doi:10.4274\/tnd.2020.36418","DOI":"10.4274\/tnd.2020.36418"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Aliyev R.R., Shiraliyeva R.K. Characteristics of patients with multiple sclerosis by sex \/\/ \u0421cientific-practical journal named after A.Aliyev \u201cThe Medicine and Science\u201d (Dedicated to the 100th anniversary of Academician Zarifa Aliyeva), \u21162 (32) 2023, 48-55","DOI":"10.61775\/2413-3302.v2i32.07"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Quliyeva A.\u0130., \u015eir\u0259liyeva R.K., \u018fliyev R.R., H\u0259s\u0259nov R.L. Bak\u0131 \u0259halisi aras\u0131nda da\u011f\u0131n\u0131q sklerozun epidemioloji v\u0259 klinik xususiyy\u0259tl\u0259ri \/\/ Milli nevrologiya jurnal\u0131, 2 (16) 2019, s\u0259h. 24-28. doi: 10.61788\/njn.v2i19.03","DOI":"10.28942\/nnj.v1i16.276"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Baghbanian S.M., Cheraghmakani H., Habibi Saravi R., Azar A. and Ghasemihamedani F. Does the multiple sclerosis (MS) map need to change again? An update of MS prevalence in Mazandaran province of Iran in 2018 \/\/ BMC Neurol. 2020 Feb 12;20(1):52. doi: 10.1186\/s12883-020-1618-6","DOI":"10.1186\/s12883-020-1618-6"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Ghandehari K., Riasi H.R., Nourian A. and Boroumand A.R. Prevalence of multiple sclerosis in north east of Iran \/\/ Mult Scler. 2010 Dec;16(12):1525-6. doi: 10.1177\/1352458510372150","DOI":"10.1177\/1352458510372150"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Boyko A\/ and Melnikov M. Prevalence and Incidence of Multiple Sclerosis in Russian Federation: 30 Years of Studies \/\/ Brain Sci. 2020 May 18;10(5):305. doi: 10.3390\/brainsci10050305","DOI":"10.3390\/brainsci10050305"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Marcoci C., Lisnic V., Gavriliuc M., Odainic O., Sangheli M. and Belenciuc A., et al. Prevalence of Multiple Sclerosis in the Republic of Moldova \/\/ Neuroepidemiology. 2016;46(3):166-72. doi: 10.1159\/000443931","DOI":"10.1159\/000443931"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Portaccio E., Magyari M., Havrdova E.K., Ruet A., Brochet B., Scalfari A., et al. Multiple sclerosis: emerging epidemiological trends and redefining the clinical course \/\/ Lancet Reg Health Eur. 2024 Aug 22;44:100977. doi: 10.1016\/j.lanepe.2024.100977","DOI":"10.1016\/j.lanepe.2024.100977"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Zhang G.X., Carrillo-Vico A., Zhang W.T., Gao S.S., Izquierdo Ayuso G. Incidence and prevalence of multiple sclerosis in China and other Asian countries \/\/ Neurologia (Engl Ed). 2023 Apr;38(3):159-172. doi: 10.1016 \/ j. nrleng.2020.07.022","DOI":"10.1016\/j.nrleng.2020.07.022"},{"key":"20","doi-asserted-by":"crossref","unstructured":"El-Salem K., Al-Shimmery E., Horany K., Al-Refai A., Al-Hayk K., Khader Y. Multiple sclerosis in Jordan: A clinical and epidemiological study \/\/ J Neurol. 2006;253(9):1210-1216. doi: 10.1007\/s00415-006-0203-2","DOI":"10.1007\/s00415-006-0203-2"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Alter M., Kahana E., Zilber N., Miller A. Multiple sclerosis frequency in Israel&apos;s diverse populations \/\/ Neurology. 2006;66(7):1061-1066. doi: 10.1212 \/01.wnl.0000204194.47925.0d","DOI":"10.1212\/01.wnl.0000204194.47925.0d"}],"container-title":["Azerbaijan Medical Journal"],"original-title":["PREVALENCE OF MULTIPLE SCLEROSIS IN THE LIBERATED TERRITORIES OF AZERBAIJAN"],"language":"az","deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T06:18:38Z","timestamp":1755670718000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.azmedjournal.com\/index.php\/amz\/article\/view\/661"}},"subtitle":["AZ\u018fRBAYCANIN \u0130\u015e\u011eALDAN AZAD ED\u0130LM\u0130\u015e \u018fRAZ\u0130L\u018fR\u0130ND\u018f DA\u011eINIQ SKLEROZUN YAYILMASI"],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":21,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,6,25]]}},"URL":"https:\/\/doi.org\/10.34921\/amj.2025.2.021","relation":{},"ISSN":["0005-2523"],"issn-type":[{"value":"0005-2523","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,25]]}}}